Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4′-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands

Journal of Inorganic Biochemistry

Volumn 101, Issue 6, 2007, Pages 881-892

  Devereux, Michael ^a   O Shea, Denis ^a   Kellett, Andrew ^a   McCann, Malachy ^b   Walsh, Maureen ^a   Egan, Denise ^a   Deegan, Carol ^a   Kedziora, Kinga ^a   Rosair, Georgina ^c   Müller Bunz, Helge ^d  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c HERIOT WATT UNIVERSITY   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

1,10 Phenanthroline; 2 (2 Pyridyl)benzimidazole; Anticancer activity; Catalase; Copper(II)benzoates; SOD; Thiabendazole

Indexed keywords

1,10 PHENANTHROLINE; 2 (2 PYRIDYL)BENZIMIDAZOLE; 2 (4' THIAZOLE)BENZIMIDAZOLE(THIABENDAZOLE); BENZIMIDAZOLE DERIVATIVE; NITROGEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOMIMETICS; CANCER CELL CULTURE; CHELATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; GEOMETRY; HUMAN; HUMAN CELL; HYDROGEN BOND; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BENZOATES; CELL LINE, TUMOR; CHELATING AGENTS; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; LIGANDS; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; NITROGEN; PHENANTHROLINES; SPECTROPHOTOMETRY, INFRARED;

EID: 34248657279     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2007.02.002     Document Type: Article

References (52)

1. Kelland L.R., Farell N.P., and Spinelli S. In: Farrell N.P. (Ed). Uses of Inorganic Chemistry in Medicine (1999), The Royal Society of Chemistry 109-134
2. In: Gielen M., and Tiekink E.R.T. (Eds). Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine (2005), Wiley
3. M. Devereux, M. McCann, D.O Shea, M.O Connor, E. Kiely, V. McKee, D. Naughton, A. Fisher, A. Kellett, M. Walsh, D. Egan, C. Deegan, Bioinorganic Chemistry and Applications (2006) Article ID 80283, pp. 1-11.
4. C. Deegan, M. McCann, M. Devereux, B. Coyle, D. Egan, 2006, Cancer Letters, doi:10.1016/j.canlet.2006.04.006.
5. Deegan C., Coyle B., McCann M., Devereux M., and Egan D. Chem. Biol. Interact. 164 (2006) 115-125
6. McCann M., Coyle B., McKay S., McCormack P., Kavanagh K., Devereux M., McKee V., Kinsela P., Connor R.O., and Clynes M. Biometals 17 (2004) 635-654
7. Huang R., Wallqvist A., and Covell D.G. Biochem. Pharmacol. 100 (2006) 1389-1398
8. Kaniskan N., and Ogretir C. J. Mol. Struct. 584 (2002) 45-52
9. Devereux M., McCann M., Shea D.O., Kelly R., Egan D., Deegan C., and McKee V. J. Inorg. Biochem. 98 (2004) 1023-1031
10. Grevy J.M., Tellez F., Bernes S., Noth H., Contreras R., and Barba-Behrens N. Inorg. Chim. Acta 339 (2002) 532-542
11. R. Kelly, M. Phill. Thesis, The Dublin Institute of Technology, Ireland, 2004.
12. Yu X.-Y., Maekawa M., Morita T., Chang H.-C., Kitagawa S., and Jin G.-X. Polyhedron 21 (2002) 1613-1620
13. He X.-F., Vogels C.M., Decken A., and Westcott S.A. Polyhedron 23 (2004) 155-160
14. Khalil M.H., Mohamed H.A., El-Medani S.M., and Ramadan R.M. Spectrachim. Acta Part A 59 (2004) 1341-1347
15. Choquesillo-Lazarte D., Covelo B., Gonzales-Perez J.M., Castineiras A., and Niclos-Gutierrez J. Polyhedron 21 (2002) 1485-1495
16. Mock C., Puscasu I., Rauterkus M.J., Tallen G., Wolff J.E.A., and Krebs B. Inorg. Chim. Acta 319 (2001) 109-116
17. Khalil M.H., Ali S.A., and Ramadan R.M. Spectrachim. Acta Part A 57 (2001) 1017-1024
18. Boca R., Boca M., Ehrenberg H., Fuess H., Linert W., Renz F., and Svoboda I. Chem. Phys. 293 (2003) 375-395
19. McDevitt M.R., Ru Y., and Addison A.W. Trans. Met. Chem. 18 2 (1993) 197-204
20. Muller-Buschbaum K., and Quitmann C.C. Inorg. Chem. 42 8 (2003) 2742-2750
21. Weser U., Sellenger K.H., Lengfelder E., Werner W., and Strähle J. Biochim. Biophys. Acta 631 (1980) 232
22. Sheldrick G.M. SADABS (2000), Bruker AXS Inc., Madison, WI 53711
23. G.M. Sheldrick, SHELXTL, (V6.14), Bruker AXS Inc., Madison, WI 53711, 2003.
24. G.M. Sheldrick, SHELXTL, (V5.1), Bruker AXS P4 Inc., Madison, WI, 1999.
25. Casey M.T., McCann M., Devereux M., Curran M., Cardin C., Convery M., Quillet V., and Harding C. J. Chem. Soc. Chem. Commun. (1994) 2643-2645
26. Goldstein S., and Czapski G. Superoxide Dismutase. In: Punchard N.A., and Kelly F.J. (Eds). Free Radicals - A Practical Approach (1996), Oxford University Press, UK 252
27. Mosmann T. J. Immunol. 65 (1983) 55-63
28. Inoue M., Kishita M., and Kubo M. Inorg. Chem. 3 (1964) 239-242
29. In: Cotton F.A., and Wilkinson G. (Eds). Advanced Inorganic Chemistry. sixth ed. (1999), Wiley, New York 867
30. Deacon G.B., and Philips R.J. Coord. Chem. Rev. 33 (1980) 227-250
31. Tian L., and Long X.-Y. Chinese J. Struct. Chem. 19 (2000) 363-367
32. Wang W.-G., Chen F., Chen C.-N., and Liu Q.-T. Chinese J. Struct. Chem. 22 (2003) 399
33. Cheng D., Liu Y., Xu D., and Xu Y. J. Coord. Chem. 48 (1999) 495
34. M. Curan, Ph.D. Thesis, National University of Ireland, 1996.
35. Devereux M., McCann M., Leon V., McKee V., and Ball R.J. Polyhedron 21 (2002) 1063-1071
36. M. Devereux, M. McCann, M.T. Casey, M. Curran, International Patent, 1994, IPA No. S940892.
37. Naruta Y., and Maruyama K. J. Chem. Soc., Chem.Comm. (1994) 2667-2669
38. Weder J.F., Dillon C.T., Hambley T.W., Kennedy B.J., Lay P.A., Biffin J.R., Regtop H.L., and Davies N.M. Coord. Chem. Rev. 232 (2002) 95-126
39. IVS Annual; MIMS Publishing, Crows Nest, NSW, Sydney, 1997, p. 145, 276.
40. Travnycek Z., Malon M., Sindelar Z., Dolezal K., Rolcik J., Krystof V., Strnad M., and Marek J. J. Inorg. Biochem. 84 (2001) 23-32
41. Belichi-Ferrari M., Capacchi S., Pelosi G., Reffo G., Tarasconi P., Albertini R., Pinelli S., and Lunghi P. Inorg. Chim. Acta 286 (1999) 134-141
42. Raptopoulou C.P., Paschalidou S., Pantazaki A.A., Terzis A., Perlepes S.P., Lialiaris T., Bakalbassis E.G., Mrozinski J., and Kyriakidis D.A. J. Inorg. Biochem. 71 (1998) 15-27
43. Khanam J.A., Bag S.P., Sur B., and Sur P. Indian J. Pharmacol. 29 (1997) 157-161
44. Zhang C.X., and Lippard S.J. Curr. Opin. Chem. Biol. 7 (2003) 481-489
45. Gracia-Mora I., Ruiz-Ramirez L., Gomez-Ruiz C., Tinoco-Mendez M., Marquez-Quinones A., Romero de Lira L., Marin-Hernandez A., Masias-Rosales L., and Bravo-Gomez M.E. Metal Based Drugs 8 (2002) 19-28
46. De Vizcaya-Ruiz A., Rivero-Mueller A., Ruiz-Ramirez L., Kass G.E.N., Kelland L.R., Or R.M., and Dobrota M. Toxicol. In Vitro 14 (2000) 1-5
47. Coyle B., Kinsella P., McCann M., Devereux M., O'Connor R., Clynes M., and Kavanagh K. Toxicol. In Vitro 18 (2004) 63-70
48. Coyle B., Kavanagh K., McCann M., Devereux M., and Geraghty M. Biometals 16 (2003) 321-329
49. Marin-Hernandez A., Gracia-Mora I., Ruiz-Remirez L., and Moreno-Sanchez R. Biochem. Pharmacol. 65 (2003) 1979-1989
50. Hirohama T., Kuranuki Y., Ebina E., Sugizaki T., Arii H., Chikira M., Selvi P.T., and Palaniandavar M. J. Inorg. Biochem. 99 (2005) 1205-1219
51. Wisniewski M.Z., Glowiak T., Opolski A., and Wietrzyk J. Metal Based Drugs 8 (2001) 189-194
52. Rivero-Müller A., De Vizcaya-Ruiz A., Plant N., Ruiz L., and Dobrota M. Chem. Biol. Interact. (2006) 10.1016/j.cbi.2006.12.002